JP2023545057A5 - - Google Patents
Info
- Publication number
- JP2023545057A5 JP2023545057A5 JP2023521336A JP2023521336A JP2023545057A5 JP 2023545057 A5 JP2023545057 A5 JP 2023545057A5 JP 2023521336 A JP2023521336 A JP 2023521336A JP 2023521336 A JP2023521336 A JP 2023521336A JP 2023545057 A5 JP2023545057 A5 JP 2023545057A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- domain
- binding
- sequence
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026002168A JP2026052693A (ja) | 2020-10-07 | 2026-01-08 | 抗デクチン－１抗体及びその使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063088895P | 2020-10-07 | 2020-10-07 | |
| US63/088,895 | 2020-10-07 | ||
| US202163174439P | 2021-04-13 | 2021-04-13 | |
| US63/174,439 | 2021-04-13 | ||
| PCT/US2021/071752 WO2022077006A1 (en) | 2020-10-07 | 2021-10-06 | Anti-dectin-1 antibodies and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026002168A Division JP2026052693A (ja) | 2020-10-07 | 2026-01-08 | 抗デクチン－１抗体及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023545057A JP2023545057A (ja) | 2023-10-26 |
| JP2023545057A5 true JP2023545057A5 (https=) | 2024-10-11 |
| JP7803942B2 JP7803942B2 (ja) | 2026-01-21 |
Family
ID=81125563
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521336A Active JP7803942B2 (ja) | 2020-10-07 | 2021-10-06 | 抗デクチン－１抗体及びその使用方法 |
| JP2026002168A Pending JP2026052693A (ja) | 2020-10-07 | 2026-01-08 | 抗デクチン－１抗体及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026002168A Pending JP2026052693A (ja) | 2020-10-07 | 2026-01-08 | 抗デクチン－１抗体及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12037399B2 (https=) |
| EP (1) | EP4225373A4 (https=) |
| JP (2) | JP7803942B2 (https=) |
| KR (1) | KR20230104617A (https=) |
| AU (1) | AU2021358659A1 (https=) |
| CA (1) | CA3198102A1 (https=) |
| IL (1) | IL301956A (https=) |
| MX (1) | MX2023004054A (https=) |
| WO (1) | WO2022077006A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230285338A9 (en) * | 2017-07-07 | 2023-09-14 | Washington University | Methods for treating microglial dysfunction |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| KR20230005907A (ko) | 2020-05-01 | 2023-01-10 | 볼트 바이오테라퓨틱스 인코퍼레이티드 | 항-dectin-2 항체 |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| CA3198102A1 (en) | 2020-10-07 | 2022-04-14 | Dren Bio, Inc. | Anti-dectin-1 antibodies and methods of use thereof |
| KR20230118887A (ko) | 2020-12-03 | 2023-08-14 | 센츄리 쎄라퓨틱스 인코포레이티드 | 유전자 조작 세포 및 이의 용도 |
| US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
| AR124414A1 (es) | 2020-12-18 | 2023-03-22 | Century Therapeutics Inc | Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable |
| CN117295820A (zh) * | 2021-03-31 | 2023-12-26 | 盐野义制药株式会社 | 以ccr8作为抗原识别的嵌合抗原受体 |
| EP4504794A1 (en) * | 2022-04-04 | 2025-02-12 | Dren Bio, Inc. | Anti-dectin-1 antibodies and methods of use thereof |
| US20250223364A1 (en) * | 2022-04-04 | 2025-07-10 | Dren Bio, Inc. | Multispecific binding proteins that bind dectin-1 and cd20 and methods of use thereof |
| JP2025532897A (ja) * | 2022-09-28 | 2025-10-03 | ドレン バイオ， インコーポレイテッド | 多重特異性抗体及びその使用方法 |
| IL326088A (en) * | 2023-07-31 | 2026-03-01 | Dren Bio Man Inc | Multispecific binding proteins that bind Dectin-1 and TROP-2 and methods of using them |
| TW202540200A (zh) | 2023-12-01 | 2025-10-16 | 美商基利科學股份有限公司 | 抗ｆａｐ－ｌｉｇｈｔ融合蛋白及其用途 |
| WO2025259871A1 (en) | 2024-06-14 | 2025-12-18 | Gilead Sciences, Inc. | Anti-ccr8 antibodies and uses thereof |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| EP0866870B1 (en) * | 1995-12-01 | 2003-03-12 | Genentech, Inc. | TISSUE FACTOR - KUNITZ DOMAIN FUSION PROTEINS AS FACTOR VIIa INHIBITORS |
| CA2704600C (en) | 1999-04-09 | 2016-10-25 | Kyowa Kirin Co., Ltd. | A method for producing antibodies with increased adcc activity |
| EP1229125A4 (en) | 1999-10-19 | 2005-06-01 | Kyowa Hakko Kogyo Kk | PROCESS FOR PREPARING A POLYPEPTIDE |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| US7064191B2 (en) | 2000-10-06 | 2006-06-20 | Kyowa Hakko Kogyo Co., Ltd. | Process for purifying antibody |
| US7405276B2 (en) * | 2000-11-01 | 2008-07-29 | Elusys Therapeutics, Inc. | Method of producing bispecific molecules by protein trans-splicing |
| CA2463879C (en) | 2001-10-25 | 2012-12-04 | Genentech, Inc. | Glycoprotein compositions |
| US20040093621A1 (en) | 2001-12-25 | 2004-05-13 | Kyowa Hakko Kogyo Co., Ltd | Antibody composition which specifically binds to CD20 |
| BR0309145A (pt) | 2002-04-09 | 2005-02-01 | Kyowa Hakko Kogyo Kk | Células das quais o genoma é modificado |
| EP1500400A4 (en) | 2002-04-09 | 2006-10-11 | Kyowa Hakko Kogyo Kk | MEDICAMENT WITH ANTIBODY COMPOSITION |
| EP1498490A4 (en) | 2002-04-09 | 2006-11-29 | Kyowa Hakko Kogyo Kk | PROCESS FOR PREPARING ANTIBODY COMPOSITION |
| CA2481925A1 (en) | 2002-04-09 | 2003-10-16 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic agent for patients having human fc.gamma.riiia |
| ATE503829T1 (de) | 2002-04-09 | 2011-04-15 | Kyowa Hakko Kirin Co Ltd | Zelle mit erniedrigter oder deletierter aktivität eines am gdp-fucosetransport beteiligten proteins |
| CA2481658A1 (en) | 2002-04-09 | 2003-10-16 | Kyowa Hakko Kogyo Co., Ltd. | Method of enhancing of binding activity of antibody composition to fcy receptor iiia |
| TWI335821B (en) | 2002-12-16 | 2011-01-11 | Genentech Inc | Immunoglobulin variants and uses thereof |
| JPWO2005035586A1 (ja) | 2003-10-08 | 2007-11-22 | 協和醗酵工業株式会社 | 融合蛋白質組成物 |
| JPWO2005035778A1 (ja) | 2003-10-09 | 2006-12-21 | 協和醗酵工業株式会社 | α１，６−フコシルトランスフェラーゼの機能を抑制するＲＮＡを用いた抗体組成物の製造法 |
| WO2005053742A1 (ja) | 2003-12-04 | 2005-06-16 | Kyowa Hakko Kogyo Co., Ltd. | 抗体組成物を含有する医薬 |
| WO2006047350A2 (en) * | 2004-10-21 | 2006-05-04 | Xencor, Inc. | IgG IMMUNOGLOBULIN VARIANTS WITH OPTIMIZED EFFECTOR FUNCTION |
| NZ573646A (en) * | 2006-06-12 | 2012-04-27 | Wyeth Llc | Single-chain multivalent binding proteins with effector function |
| MX2009008926A (es) * | 2007-02-23 | 2009-09-14 | Baylor Res Inst | Aplicaciones terapeuticas de activacion de celulas que presentan antigeno humano por medio de detectina a-1. |
| US8844834B1 (en) | 2009-10-30 | 2014-09-30 | C. Cowles & Company | Thermal reduction through activity based thermal targeting to enhance heating system efficiency |
| US20120244155A1 (en) | 2011-03-22 | 2012-09-27 | Baylor Research Institute | Dendritic Cells (DCs) Targeting for Tuberculosis (TB) Vaccine |
| WO2013033104A1 (en) * | 2011-08-29 | 2013-03-07 | Baylor Research Institute | CONTROLLING ALLERGY AND ASTHMA BY ACTIVATING HUMAN DCs VIA DECTIN-1 OR DECTIN-1 AND TOLL-LIKE RECEPTOR 2 (TLR2) |
| RS60499B1 (sr) * | 2011-12-20 | 2020-08-31 | Medimmune Llc | Modifikovani polipeptidi za bispecifične skelete antitela |
| JP6509724B2 (ja) * | 2012-04-20 | 2019-05-08 | アプティーボ リサーチ アンド デベロップメント エルエルシー | Ｃｄ３結合ポリペプチド |
| AU2013322710A1 (en) | 2012-09-25 | 2015-04-16 | Glenmark Pharmaceuticals S.A. | Purification of hetero-dimeric immunoglobulins |
| US20160185837A1 (en) * | 2013-08-16 | 2016-06-30 | Medimmune Limited | Gip and glp-1 receptor dual-agonists for the treatment of diabetes |
| JP6668345B2 (ja) | 2014-11-21 | 2020-03-18 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 修飾された重鎖定常領域を含む抗体 |
| AR108377A1 (es) | 2016-05-06 | 2018-08-15 | Medimmune Llc | Proteínas de unión biespecíficas y sus usos |
| US20190336615A1 (en) | 2017-01-27 | 2019-11-07 | Silverback Therapeutics, Inc. | Tumor targeting conjugates and methods of use thereof |
| RU2019134273A (ru) * | 2017-03-31 | 2021-04-30 | Займворкс Инк. | Конструкты индуктора презентации антигена опухоли и их использование |
| TWI828625B (zh) * | 2017-06-25 | 2024-01-11 | 美商西雅圖免疫公司 | 引導及導航控制蛋白質以及彼之製造及使用方法 |
| AU2018313810B2 (en) | 2017-08-09 | 2025-05-15 | Orionis Biosciences BV | Clec9A binding agents and use thereof |
| JP7535494B2 (ja) | 2018-07-19 | 2024-08-16 | オンコホスト リミテッド | 癌に対するマクロファージベースの養子細胞療法の有効性を改善するｉｌ－３１ |
| AU2020253621A1 (en) | 2019-04-05 | 2021-11-11 | Dren Bio Management, Inc. | Methods of depleting disease causing agents via antibody targeted phagocytosis |
| CA3198102A1 (en) | 2020-10-07 | 2022-04-14 | Dren Bio, Inc. | Anti-dectin-1 antibodies and methods of use thereof |
-
2021
- 2021-10-06 CA CA3198102A patent/CA3198102A1/en active Pending
- 2021-10-06 IL IL301956A patent/IL301956A/en unknown
- 2021-10-06 EP EP21878726.5A patent/EP4225373A4/en active Pending
- 2021-10-06 JP JP2023521336A patent/JP7803942B2/ja active Active
- 2021-10-06 US US17/495,712 patent/US12037399B2/en active Active
- 2021-10-06 AU AU2021358659A patent/AU2021358659A1/en active Pending
- 2021-10-06 WO PCT/US2021/071752 patent/WO2022077006A1/en not_active Ceased
- 2021-10-06 KR KR1020237015287A patent/KR20230104617A/ko active Pending
- 2021-10-06 MX MX2023004054A patent/MX2023004054A/es unknown
-
2025
- 2025-07-08 US US19/263,140 patent/US20260035469A1/en active Pending
-
2026
- 2026-01-08 JP JP2026002168A patent/JP2026052693A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023545057A5 (https=) | ||
| JP7058219B2 (ja) | Ｃｄ３及びｐｓｍａに結合するヘテロ二量体抗体 | |
| US12398207B2 (en) | Heterodimeric antibodies that bind CD3 and CLDN6 | |
| JP2025511391A5 (https=) | ||
| US20210253736A1 (en) | Heterodimeric antibodies that bind fibroblast activation protein | |
| JP2023123726A5 (https=) | ||
| JP2018183173A5 (https=) | ||
| JP2022529154A5 (https=) | ||
| JP2021525544A5 (https=) | ||
| JP2024541680A5 (https=) | ||
| US12404329B2 (en) | Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3 | |
| JP7657591B2 (ja) | 二重特異性抗原結合コンストラクト | |
| JP2023548529A5 (https=) | ||
| JP2022515258A5 (https=) | ||
| JP2025532897A (ja) | 多重特異性抗体及びその使用方法 | |
| US20250084179A1 (en) | Anti-cd28 x anti-trop2 antibodies | |
| JP2026027248A (ja) | 抗原結合分子およびその使用 | |
| JP2024543822A5 (https=) | ||
| JP2019518473A5 (https=) | ||
| JP2024509274A (ja) | Ｃｄ３及びｇｐｃ３に結合するヘテロ二量体抗体 | |
| TW202525853A (zh) | 抗ｃｄ２０ｘ抗ｃｄ２８組合療法 | |
| JP2023507280A5 (https=) | ||
| WO2026080752A2 (en) | De novo antibodies to activin a receptor like type 1 (alk1) | |
| WO2025024780A1 (en) | Antibodies that bind gamma-delta t cell receptors for the treatment of cancer | |
| TW202436345A (zh) | 抗ｃｄ３多特異性抗體及使用方法 |